Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Insulin Detemir Combined With OAD Versus Insulin NPH Combined With OAD in Type 2 Mellitus

NCT00604396 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT00604396
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00604396 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Insulin Detemir Combined With OAD Versus Insulin NPH Combined With OAD in Type 2 Mellitus
Lead sponsor
Novo Nordisk A/S
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2003
Completion date
January 31, 2004
Enrollment
477 (actual)
Sites
62

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, diabetes mellitus, type 2